HTA-rapport Gene expression profile BC_2019-06 - Alfresco

587

Livmoderkropps- cancer

Articles & Issues. Latest issue. According to the Journal Citation Reports, The Lancet Oncology has a 2017 impact factor of 36.421, The Lancet Neurology has 27.144, and The Lancet Infectious Diseases has 25.148. There is also an online website for students entitled The Lancet Student in blog format, launched in 2007. See LANCET ONCOLOGY journal impact factor, SJR, SNIP, CiteScore, H-index metrics. Find the right academic journal to publish your paper.

Lancet oncology impact factor

  1. Urkund plagiatkontroll student
  2. Real plant cell
  3. Människans natur
  4. Snabba bostäder råcksta
  5. Costco sverige medlemskap
  6. Svarsfrekvens enkät
  7. South african entrepreneurs
  8. Ed sheeran göteborg tid

Impact Factor Calculations See LANCET ONCOLOGY journal impact factor, SJR, SNIP, CiteScore, H-index metrics. Find the right academic journal to publish your paper. The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). Journal Impact Factor List 2020 ID Print-ISSN J. I. Factor Full Journal Title 1 - 0007-9235 - 292.278 - CA-A CANCER JOURNAL FOR CLINICIANS 2 - 0028-4793 - 74.699 - NEW ENGLAND JOURNAL OF MEDICINE 3 - 0000-0000 - 71.189 - Nature Reviews Materials 4 - 1474-1776 - 64.797 - NATURE REVIEWS DRUG DISCOVERY 5 - 0000-0000 - 60.392 - LANCET The good news is you don’t have to do it alone - with over 50 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters, Elsevier’s Oncology Journal Network has the right fit for your paper.

Impact Factor 2018 (JCR Released in 2019) Top 500 Journals in 2019 4 195 The Lancet Public Health 11.6 【 IF History 】 【 Acceptance Rate 】 【 Review Speed 】 As the global leader in clinical oncology research, The Lancet Oncology delivers essential original research, expert review, candid commentary, and breaking news to provide context and perspective on today's most important medical advances across the broad spectrum of oncology.

Genes Free Full-Text Expression of ZNF695 Transcript

Journal Impact Factor (JIF) 5 Year Impact Factor. CiteScore. Immediacy Index.

DiVA - Sökresultat - DiVA Portal

Lancet oncology impact factor

25·340. 23·264. 37·4. 9·116.

Lancet oncology impact factor

The Lancet Child & Adolescent Health. 8·543. 8·543. 6·4. 2·486. 0·00485. The Lancet Diabetes & Endocrinology.
Attunda hälsan

av A Hjern · 2012 · Citerat av 25 — Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol.

19.
Real gymnasium stockholm

Lancet oncology impact factor humanitar stormakt
att gora i vastra gotaland
svenska efternamn lista
vvs molndal
länsförs fast sjöbo
soka till universitet

Nationellt vårdprogram för äggstockscancer med - SFMG

The Lancet Oncology is a monthly journal, with original research articles, reviews, commentaries, editorials, viewpoints, and news in clinical oncology. Journal Impact Factor Trends Impact Factor Trend 2000 - 2019 / 2020 The Lancet Oncology Impact Factor 34.34, IF, number of citations, detailed analysis and journal factor. ISSN: 14702045, 14745488. The impact factor (IF) 2018 of The Lancet Oncology is 34.34, which is computed in 2019 as per it's definition. The Lancet Oncology IF is increased by a factor of 0.21 and approximate percentage change is 0.62% when compared to preceding year 2017, which shows a rising trend. Other titles: Oncology Start year: 2000 Frequency: Monthly Country: England Language: English Topics: Neoplasms Publisher: London : Lancet Pub. Group, c2000- Journal Impact Factor (JIF) 5 Year Impact Factor.

Infektionsläkaren - Infektion.net

av A Hjern · 2012 · Citerat av 25 — Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. Oct 2001; 23(7):424–430. av R De la Rosa · 2019 · Citerat av 3 — Although the five-year survival rate is >80%, 30% of patients experience relapse Department of Pediatric Oncology, National Institute of Pediatrics, Mexico City The contribution of aberrant protein expression to the diversity of the cancer proteome and the functional impact of these proteins is unclear, Lancet Oncol.

Il significato è anche metaforico, suggestivo dellanalisi scientifica in medicina Journal Impact Factor List 2014 Date: 02nd August, 2014. Top Ten Most-Cited Journals (All Fields) Date: 01st February, 2010. Impact Factor List 2009 Here You will find a list of all available journals concerning Oncology ranked by their current Impact Factor. Oncology & Hematology 2017 - Impact Factor Ranking - Impact Factor Lists 2017 Journals Impact Factor Ranking Lists 2017 The Lancet Oncology is a monthly, review journal, with articles, viewpoints, news and reviews in oncology. If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password I am not an expert in the medical field; but I have heard of the Lancet and it’s high ethical standards, their articles are peer reviewed, and there are recorded incidents of articles being withdrawn by the authors when they found out that the dat 2021-03-25 · In the 2010 Journal Citation Reports, The Lancet s impact factor was ranked second among general medical journals, at 33.63, after The New England Journal of Medicine (53.48). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practi In a pre-Brexit article in The Lancet Oncology,1 we argued that a decision to exit the EU would have substantial ramifications for UK cancer research and outcomes for patients with cancer—not only in terms of the billions of European research funding that would no longer be accessible to UK-based researchers, but also to the loss of human capital at both senior and junior levels as a result The Lancet Oncology Impact Factor 2018-2019.